VytronUS raises $49m to support cardiac mapping & ablation system
Cardiac mapping & ablation system developer VytronUS said today it raised $49 million in a Series C round of equity financing. Funds from the round will go to support technology refinements and...
View ArticleMicro Interventional Devices wins FDA nod for Permaseal
Micro Interventional Devices said today it won FDA 510(k) clearance for its Permaseal transapical access and closure device. The Permaseal device is designed to allow surgeons to access and close the...
View ArticleMedtronic touts 5-year Endurant stent graft data
More than 5 years after Medtronic‘s (NYSE:MDT) Endurant Stent Graft System 1st gained FDA approval, the medical device giant has released data pointing to long-term durability of the treatment for...
View ArticleMassDevice.com +5 | The top 5 medtech stories for July 29, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleFormer AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss | Personnel...
Former AcuFocus CEO Mazzo moves to head Ophthamology at Zeiss Carl Zeiss Meditec (ETR:AFX) said this week it tapped ex-AcuFocus CEO James Mazzo as the global president of its ophthalmology business as...
View ArticleTechnology alone may not close disparities in medical research
(Reuters) – Internet technologies may help underserved populations participate in medical research studies, but relying on those technologies to get broader participation isn’t likely to work, a new...
View ArticleAlcon wins FDA nod for CyPass Micro-Stent
Novartis (NYSE:NVS)’s Alcon unit won FDA clearance for its CyPass Micro-stent designed to reduce intraocular pressure in patients suffering from glaucoma, according to an FDA release posted today. The...
View ArticleUDI guidance: Five key steps to FDA unique device identifier compliance
By Stewart Eisenhart, Emergo Group New guidance from the US Food and Drug Administration lays out key components of Unique Device Identifier (UDI) form and content that medical device manufacturers...
View ArticleVerily, GlaxoSmithKline partner to form $713m joint Galvani Bioelectronics
GlaxoSmithKline (NYSE:GSK) said today it is partnering with Google‘s (NSDQ:GOOG) Verily to form Galvani Bioelectronics, a new firm focused on bioelectronic medicine. Bioelectronic medicine operates...
View ArticleIntuitive partners with Dextera on robotic surgery stapler
Intuitive Surgical (NSDQ:ISRG) said it inked a joint development deal with Dextera Surgical (NSDQ:DXTR) to develop a surgical stapler and cartridge for Intuitive’s da Vinci robotic surgical system. The...
View ArticleIntersect ENT files with FDA for drug-delivering sinus implant
Intersect ENT (NSDQ:XENT) said today it submitted a supplemental premarket approval submission to the FDA seeking approval for a new Nova steroid releasing implant for treating patients with chronic...
View ArticlePhilips releases set of connected mobile health tools
Royal Philips (NYSE:PHG) today announced the launch of a series of connected personal health devices , including a health monitoring watch, scale, blood pressure monitor and thermometer, all designed...
View ArticleMedtronic wins expanded CE Mark for Evolut R TAVR system
Medtronic (NYSE:MDT) said today it won expanded CE Mark approval in the European Union for its CoreValve Evolut R transcatheter aortic valve replacement, now approved for aortic stenosis patients at...
View ArticleHaemonetics sees shares rise on Q1 release
Haemonetics (NYSE:HAE) has seen shares rise despite releasing 1st quarter earnings that saw losses grow and earnings per share shrink compared to last year. The Braintree, Mass.-based company reported...
View ArticleEssential Medical wins FDA IDE nod for vascular sealer
Essential Medical said today it won an Investigational Device Exemption from the FDA to begin a trial of its X-Seal 6F vascular closure device. The 180-patient pivotal study will run across 10-16 sites...
View ArticleInvuity prices $28m offering
Invuity (NSDQ:IVTY) last week priced a new $28 million public offering of common shares, looking to float $2.8 million shares at $10 a piece. The new offering comes with a 30-day underwriters option to...
View ArticleMassDevice.com +5 | The top 5 medtech stories for August 1, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleCantel Medical picks up Accutron for $52m
Cantel Medical (NYSE:CMN) said today it acquired Accutron for approximately $52.5 million. Accutron manufactures nitrous oxide delivery systems and single-use nasal masks, and will be folded into the...
View ArticleMedpace prices $161m IPO
Contract research organization Medpace today released the pricing for its initial public offering, looking to float 7 million shares at between $20 and $23 per share, which will bring in between $140...
View ArticleReVision Optics touts Raindrop inlay study data
ReVision Optics today released results from a trial of its Raindrop near vision inlay, touting significantly improved near and immediate vision and no loss of distance binocular acuity in subjects with...
View Article